Cargando…

Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study

INTRODUCTION: The ICH E9 addendum outlining the estimand framework for clinical trials was published in 2019 but provides limited guidance around how to handle intercurrent events for non-inferiority studies. Once an estimand is defined, it is also unclear how to deal with missing values using princ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rehal, Sunita, Cro, Suzie, Phillips, Patrick PJ, Fielding, Katherine, Carpenter, James R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504812/ https://www.ncbi.nlm.nih.gov/pubmed/37277978 http://dx.doi.org/10.1177/17407745231176773

Ejemplares similares

Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022)

Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022)

Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands
por: Cro, Suzie, et al.
Publicado: (2022)

Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data
por: Wharton, Sean, et al.
Publicado: (2021)

Estimands in published protocols of randomised trials: urgent improvement needed
por: Kahan, Brennan C., et al.
Publicado: (2021)

Eliminating Ambiguous Treatment Effects Using Estimands
por: Kahan, Brennan C, et al.
Publicado: (2023)

PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives
por: Skaltsa, K., et al.
Publicado: (2020)

Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals
por: Rehal, Sunita, et al.
Publicado: (2016)

Blinded Outcome Assessment Was Infrequently Used and Poorly Reported in Open Trials
por: Kahan, Brennan C., et al.
Publicado: (2015)

Risk of selection bias in randomised trials
por: Kahan, Brennan C., et al.
Publicado: (2015)

A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic
por: Cro, Suzie, et al.
Publicado: (2020)

Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions
por: Kahan, Brennan C., et al.
Publicado: (2020)

Estimands for factorial trials
por: Kahan, Brennan C., et al.
Publicado: (2022)

Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials
por: Li, Hong, et al.
Publicado: (2022)

Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool
por: Cro, Suzie, et al.
Publicado: (2023)

Intercurrent events in clinical research: the norm, not the exception
por: Rojas-Saunero, L. Paloma, et al.
Publicado: (2022)

Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial
por: Weir, Isabelle R, et al.
Publicado: (2023)

Understanding estimands
por: Gogtay, Nithya Jaideep, et al.
Publicado: (2021)

Estimands: bringing clarity and focus to research questions in clinical trials
por: Clark, Timothy Peter, et al.
Publicado: (2022)

Cerebral Meningitis (Intercurrent)
por: Hay, Walter
Publicado: (1875)

Intercurrent Remedies for Chronic Diseases
Publicado: (1889)

A framework for handling missing accelerometer outcome data in trials
por: Tackney, Mia S., et al.
Publicado: (2021)

Estimands and Complex Innovative Designs
por: Collignon, Olivier, et al.
Publicado: (2022)

Analytical approaches and estimands to take account of missing patient-reported data in longitudinal studies
por: Bell, Melanie L, et al.
Publicado: (2019)

Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods
por: Olarte Parra, Camila, et al.
Publicado: (2022)

Reference‐based multiple imputation for missing data sensitivity analyses in trial‐based cost‐effectiveness analysis
por: Leurent, Baptiste, et al.
Publicado: (2019)

Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled trials
por: Cornelius, Victoria, et al.
Publicado: (2020)

Estimands in epigenome-wide association studies
por: Kruppa, Jochen, et al.
Publicado: (2021)

Estimands—What they are and why they are important for pharmacometricians
por: Akacha, Mouna, et al.
Publicado: (2021)

Current approaches to handling rescue medication in asthma and eczema randomized controlled trials are inadequate: a systematic review
por: Chis Ster, Anca Maria, et al.
Publicado: (2020)

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials
por: Kahan, Brennan C, et al.
Publicado: (2014)

Immunity against Helminths: Interactions with the Host and the Intercurrent Infections
por: Moreau, Emmanuelle, et al.
Publicado: (2010)

Variance estimation in reference based sensitivity analysis for longitudinal trials with protocol deviation
por: Cro, Suzie, et al.
Publicado: (2015)

Some considerations on target estimands for health technology assessment
por: Remiro‐Azócar, Antonio
Publicado: (2022)

The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol
por: Morden, Andrew, et al.
Publicado: (2015)

Gestational diabetes mellitus and the role of intercurrent type 2 diabetes on long-term risk of cardiovascular events
por: Sun, Jiyu, et al.
Publicado: (2021)

The Physical Examination of the Chest in Pulmonary Consumption and Its Intercurrent Diseases
Publicado: (1861)

Retrospective study on intercurrent pancreatitis with Babesia gibsoni infection in dogs
por: MASUDA, Misa, et al.
Publicado: (2019)

Diathesis and Cachexiæ during Intercurrent Attacks—The Importance of Their Recognition and Treatment
por: Winston, Geo. H.
Publicado: (1890)

On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies
por: Unkel, Steffen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ef30c14d0mdnqocoq1j0ebfkvk